Int Cardiovasc Res J. 2014 Dec;8(4):152-5. Epub 2014 Dec 01.
Incidence and outcome of documented fungal endocarditis.
International cardiovascular research journal
Parisa Badiee, Ahmad Ali Amirghofran, Mohammad Ghazi Nour, Masih Shafa, Mohammad Hassan Nemati
Affiliations
Affiliations
- Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran.
- Cardiothoracic Surgery Unit, Shiraz University of Medical Sciences, Shiraz, IR Iran.
PMID: 25614858
PMCID: PMC4302502
Abstract
BACKGROUND: Fungal endocarditis, the most severe form of infective endocarditis, is characterized by excessive mortality and morbidity.
OBJECTIVES: The present study aimed to analyze the characteristics of fungal endocarditis to improve the management of these patients.
MATERIALS AND METHODS: In this cross-sectional study, vegetations on the mitral or tricuspid valves and embolic material surgically removed from the patients with suspected infective endocarditis between December 2009 and November 2011 were examined for fungal infection by direct smear and culture, and the susceptibility patterns of the isolated species were determined. Then, blood samples were cultured on BACTEC media and real-time PCR was done with blood and tissue samples.
RESULTS: Of the 31 patients with suspected infective endocarditis who did not respond to antibacterial therapy, 11 had confirmed fungal endocarditis. The most frequent predisposing risk factors were previous surgery and drug abuse. The organisms isolated were Aspergillus spp. and Candida albicans. Resistance to amphotericin B and itraconazole was observed in Aspergillus species, and to fluconazole in Candida albicans. Positive PCR results were obtained in blood and tissue samples.
CONCLUSIONS: Fungal endocarditis should be considered in the patients not responsive to antimicrobials. Moreover, management of these patients can be improved with molecular diagnostic methods and by determining the susceptibility patterns of the etiologic agents.
Keywords: Aspergillus; Candida; Endocarditis; Fungus Susceptibility
References
- Pediatr Cardiol. 2005 Sep-Oct;26(5):517-36 - PubMed
- Clin Infect Dis. 2000 Apr;30(4):633-8 - PubMed
- Clin Infect Dis. 2001 Jan;32(1):50-62 - PubMed
- Ann Intern Med. 1988 Jan;108(1):88-100 - PubMed
- J Infect Dev Ctries. 2010 Sep 03;4(8):511-6 - PubMed
- Rev Esp Cardiol. 1998;51 Suppl 2:79-85 - PubMed
- J Infect Dis. 1991 Oct;164(4):731-40 - PubMed
- Medicine (Baltimore). 2009 May;88(3):160-8 - PubMed
- Eur Heart J. 1995 Apr;16 Suppl B:84-9 - PubMed
- East Mediterr Health J. 2011 May;17(5):425-30 - PubMed
- J Clin Microbiol. 2006 Mar;44(3):760-3 - PubMed
- J Clin Microbiol. 1999 Jan;37(1):165-70 - PubMed
- Exp Clin Transplant. 2010 Jun;8(2):98-103 - PubMed
- Chest. 2002 Jul;122(1):302-10 - PubMed
- Circulation. 2005 Mar 22;111(11):1352-4 - PubMed
- J Hosp Infect. 2002 Feb;50(2):91-105 - PubMed
- Circulation. 2005 Mar 22;111(11):1415-21 - PubMed
- Clin Infect Dis. 2001 Nov 1;33(9):1504-12 - PubMed
- Semin Thorac Cardiovasc Surg. 1995 Jan;7(1):2-6 - PubMed
- Arch Iran Med. 2010 Jul;13(4):282-7 - PubMed
Publication Types